0001415889-21-003597.txt : 20210713
0001415889-21-003597.hdr.sgml : 20210713
20210713180210
ACCESSION NUMBER: 0001415889-21-003597
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210709
FILED AS OF DATE: 20210713
DATE AS OF CHANGE: 20210713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sheena Jonathan
CENTRAL INDEX KEY: 0001646649
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 211088835
MAIL ADDRESS:
STREET 1: C/O NATERA, INC.
STREET 2: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
4
1
form4-07132021_030754.xml
X0306
4
2021-07-09
0001604821
Natera, Inc.
NTRA
0001646649
Sheena Jonathan
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
AUSTIN
TX
78753
true
false
false
true
CO-FOUNDER
Common Stock
2021-07-09
4
M
0
378
5.3953
A
456008
D
Common Stock
2021-07-09
4
M
0
346
9.59
A
456354
D
Common Stock
2021-07-09
4
M
0
2200
10.41
A
458554
D
Common Stock
2021-07-09
4
M
0
2623
9.29
A
461177
D
Common Stock
2021-07-09
4
S
0
5547
121
D
455630
D
Common Stock
2021-07-12
4
M
0
65
5.3953
A
455695
D
Common Stock
2021-07-12
4
M
0
32
9.59
A
455727
D
Common Stock
2021-07-12
4
M
0
488
10.41
A
456215
D
Common Stock
2021-07-12
4
M
0
784
9.29
A
456999
D
Common Stock
2021-07-12
4
S
0
1201
121.2966
D
455798
D
Common Stock
2021-07-12
4
S
0
168
122.6819
D
455630
D
Stock Option (right to buy)
5.3953
2021-07-09
4
M
0
378
0
D
2024-12-09
Common Stock
378
1580
D
Stock Option (right to buy)
9.59
2021-07-09
4
M
0
346
0
D
2026-04-07
Common Stock
346
40432
D
Stock Option (right to buy)
10.41
2021-07-09
4
M
0
2200
0
D
2027-06-08
Common Stock
2200
36168
D
Stock Option (right to buy)
9.29
2021-07-09
4
M
0
2623
0
D
2028-03-08
Common Stock
2623
18830
D
Common Stock
5.3953
2021-07-12
4
M
0
65
0
D
2024-12-09
Common Stock
65
1515
D
Common Stock
9.59
2021-07-12
4
M
0
32
0
D
2026-04-07
Common Stock
32
40400
D
Common Stock
10.41
2021-07-12
4
M
0
488
0
D
2027-06-08
Common Stock
488
35680
D
Common Stock
9.29
2021-07-12
4
M
0
784
0
D
2028-03-08
Common Stock
784
18046
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.08 to $121.77 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.17 to $123.03 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option shares vested fully and became exercisable on November 20, 2019.
The option shares vested fully and became exercisable on April 1, 2020.
The option shares vested fully and became exercisable on March 21, 2021.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.
/s/ Tami Chen, Attorney-in-Fact
2021-07-13